• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者血清镁与心血管疾病危险因素之间的关联。

Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.

作者信息

Khatami Mohammad Reza, Mirchi Elham, Khazaeipour Zahra, Abdollahi Alireza, Jahanmardi Afsaneh

机构信息

Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Kidney Dis. 2013 Jan;7(1):47-52.

PMID:23314142
Abstract

INTRODUCTION

There are associations between serum magnesium level and some risk factors of cardiovascular disease and atherosclerosis, such as lipid profile, serum albumin, C-reactive protein, serum phosphorus, parathyroid hormone, and diabetes mellitus in hemodialysis patients. The aim of this study was to examine these associations.

MATERIALS AND METHODS

This study was conducted on 103 patients with end-stage renal disease on maintenance hemodialysis. Laboratory assessment was performed before hemodialysis session in a 12-hour fasting state. Patients were divided into two groups according to their serum magnesium concentration < 2.6 mg/dL, n = 34 and >= 2.6 mg/dL, n = 69).

RESULTS

The mean age of the patients was 57.4 +/- 15.4 years. The mean serum magnesium was 2.80 +/- 0.55 mg/dL (range, 1.7 mg/dL to 7 mg/dL). There were no significant differences in serum magnesium between patients with low and high values of high-density lipoprotein cholesterol, triglycerides, low-density lipoprotein cholesterol, and blood pressure. Of the 103 patients, 1 (1%) had hypomagnesemia, 41 (39.8%) had magnesium levels within normal range, and 61 (59.2%) had hypermagnesemia. Serum magnesium significantly correlated with plasma phosphorus level (r = 0.35, P < .001) and albumin (r = 0.24, P = .01). There were no correlations between serum magnesium level and age, body mass index, systolic blood pressure before dialysis, serum calcium, lipid profile, and apoprotein(a).

CONCLUSIONS

In our cohort of hemodialysis patients, there were no correlations between serum magnesium levels and atherogenic lipids, serum calcium, or parathyroid hormone.

摘要

引言

血清镁水平与心血管疾病和动脉粥样硬化的一些危险因素之间存在关联,如血液透析患者的血脂谱、血清白蛋白、C反应蛋白、血清磷、甲状旁腺激素和糖尿病。本研究的目的是检验这些关联。

材料与方法

本研究对103例维持性血液透析的终末期肾病患者进行。在透析前12小时禁食状态下进行实验室评估。根据血清镁浓度将患者分为两组,血清镁浓度<2.6mg/dL(n = 34)和≥2.6mg/dL(n = 69)。

结果

患者的平均年龄为57.4±15.4岁。平均血清镁为2.80±0.55mg/dL(范围为1.7mg/dL至7mg/dL)。高密度脂蛋白胆固醇、甘油三酯、低密度脂蛋白胆固醇和血压高低值患者之间的血清镁无显著差异。103例患者中,1例(1%)有低镁血症,41例(39.8%)镁水平在正常范围内,61例(59.2%)有高镁血症。血清镁与血浆磷水平显著相关(r = 0.35,P <.001)和白蛋白(r = 0.24,P =.01)。血清镁水平与年龄、体重指数、透析前收缩压、血清钙、血脂谱和载脂蛋白(a)之间无相关性。

结论

在我们的血液透析患者队列中,血清镁水平与致动脉粥样硬化脂质、血清钙或甲状旁腺激素之间无相关性。

相似文献

1
Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.血液透析患者血清镁与心血管疾病危险因素之间的关联。
Iran J Kidney Dis. 2013 Jan;7(1):47-52.
2
Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.维持性血液透析患者血清镁与血脂异常的相关性
Saudi J Kidney Dis Transpl. 2012 Jan;23(1):21-5.
3
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
4
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.非高密度脂蛋白胆固醇(non-HDL-C)作为终末期肾病患者心血管死亡的预测指标。
Kidney Int Suppl. 2003 May(84):S117-20. doi: 10.1046/j.1523-1755.63.s84.30.x.
5
Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.保守治疗或长期血液透析的慢性肾病患者的心肌肌钙蛋白I
Kardiol Pol. 2007 Sep;65(9):1068-75; discussion 1076-8.
6
Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.血液透析和腹膜透析患者的心血管危险因素
Saudi J Kidney Dis Transpl. 2010 Jan;21(1):59-62.
7
Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.终末期肾病患者的血浆同型半胱氨酸水平与心血管死亡率
J Nephrol. 2004 May-Jun;17(3):405-10.
8
Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.调节胞质钙的因素。在腹膜透析患者脂质代谢及心血管发病率和死亡率中的作用。
Adv Perit Dial. 2001;17:29-36.
9
Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients.低密度脂蛋白胆固醇:与血液透析患者死亡率及住院率的关联
Blood Purif. 2005;23(2):134-40. doi: 10.1159/000083529. Epub 2005 Jan 21.
10
Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.血液透析患者中致动脉粥样硬化血脂谱和脂蛋白(a)与血清白蛋白的关系
Nephrol Dial Transplant. 1995;10(9):1668-71.

引用本文的文献

1
The Role of Magnesium in the Pathogenesis of Metabolic Disorders.镁在代谢紊乱发病机制中的作用。
Nutrients. 2022 Apr 20;14(9):1714. doi: 10.3390/nu14091714.
2
Crosstalk of Magnesium and Serum Lipids in Dyslipidemia and Associated Disorders: A Systematic Review.镁与血脂异常及相关疾病的相互作用:系统评价。
Nutrients. 2021 Apr 22;13(5):1411. doi: 10.3390/nu13051411.
3
Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
血清镁、死亡率与慢性肾脏病和终末期肾病患者的心血管疾病:系统评价和荟萃分析。
J Nephrol. 2019 Oct;32(5):791-802. doi: 10.1007/s40620-019-00601-6. Epub 2019 Mar 19.
4
Low Magnesium Exacerbates Osteoporosis in Chronic Kidney Disease Patients with Diabetes.低镁血症会加重伴发糖尿病的慢性肾脏病患者的骨质疏松症。
Int J Endocrinol. 2015;2015:380247. doi: 10.1155/2015/380247. Epub 2015 Jul 27.
5
Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.慢性肾脏病中的低镁血症与致动脉粥样硬化性血脂异常:心血管风险增加的替代标志物
Clin Exp Nephrol. 2015 Dec;19(6):1054-61. doi: 10.1007/s10157-015-1097-z. Epub 2015 Feb 20.